Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US. (via REUTERS) COURTESY BY: https://www.hindustantimes.com/ Gilead Sciences which manufactures remdesivir, is focussed on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Daniel O’Day said on Friday. Gilead has already said it will donate the first 1.5 million doses of remdesivir and O’Day told NBC’s “Today” show that the company understood its responsibility to make a difference during…